MedPath

Studing the Effect of Vitamin D Deficiency Treatment on Insulin Resistance

Phase 2
Conditions
Diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT2015070623083N1
Lead Sponsor
Vice chancellor of research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Age more than 18; Vitamin D deficiency( lower than 30 ng/ml)
Exclusion criteria:
Age more than 70; Severe underlying disease such as Malignancy, End-Stage Renal Disease, Cirrhosis, Connective tissue disease, Congestive Heart Failure; Pregnancy; Autoimmune disease such as Lupus; Acute or Chronic Infection; Psychiatric diseases under treatment; Recieving Vitamin D supplement during 1 month before study begins.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eptin level. Timepoint: Baseline and After intervension. Method of measurement: Laboratory methods with Kits.;Level of vitamin D. Timepoint: Baseline and After intervension. Method of measurement: Laboratory methods with Kits.;Relation between Leptin, Adiponectin and Leptin to Adiponectin ratio after treating 25Hydroxy Vitamin D levels. Timepoint: After intervention. Method of measurement: Laboratory kits and then divide Leptin level to Adiponectin level.;Adiponectin level. Timepoint: Baseline and after intervension. Method of measurement: Laboratory methods with Kits.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath